In high-risk patients, both Paxlovid, and molnupiravir were shown to reduce the chances of hospitalization or death from COVID-19, although Pfizer's was much more effective.
from Top World News- News18.com https://ift.tt/3FuEUT9
https://ift.tt/eA8V8J
from Top World News- News18.com https://ift.tt/3FuEUT9
https://ift.tt/eA8V8J